You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Independent Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
Has Results
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostate Cancer Trial in Argentina, United States (Sagopilone (ZK 219477) + prednisone)

Completed
  • Prostate Cancer
  • Sagopilone (ZK 219477) + prednisone
  • Fountain Valley, California
  • +16 more
Apr 6, 2021

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Radiotherapy and Androgen Deprivation In Combination After Local

Not yet recruiting
  • Prostate Cancer
  • Luteinising Hormone-Releasing Factor Analogue
  • (no location specified)
Nov 16, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Prostate Cancer Trial in Atlanta (Genistein, Placebo)

Terminated
Has Results
  • Prostate Cancer
  • Atlanta, Georgia
    Emory University
Sep 7, 2022

Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Radiation Therapy
  • Androgen Deprivation Therapy (ADT)
  • Washington, District of Columbia
  • +2 more
Oct 25, 2022

Androgen Metabolism, Metabolic Disease and Skeletal Muscle

Not yet recruiting
  • Hypogonadism, Male
  • +10 more
  • Dublin 9, Ireland
    Beaumont Hospital
Mar 16, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker

Completed
  • Recurrent Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v7
  • Ipilimumab
  • +3 more
  • San Francisco, California
    UCSF Medical Center-Mount Zion
Jul 29, 2020

Prostate Cancer Trial in San Francisco (STAND-T platform, Survey Administration, Text Messages)

Recruiting
  • Prostate Cancer
  • STAND-T platform
  • +2 more
  • San Francisco, California
  • +1 more
Oct 26, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic Trial in Boston (Aerobic and resistance exercise,

Recruiting
  • Androgen Deprivation Therapy
  • +2 more
  • Aerobic and resistance exercise
  • Usual Care
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 4, 2022

Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Hormone Sensitive Prostate Cancer
  • Beijing, China
  • +29 more
Jan 7, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

    Not yet recruiting
    • Castration Sensitive Prostate Cancer
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 12, 2023

    Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

    Active, not recruiting
    • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
    • Docetaxel injection
    • +2 more
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 24, 2022

    Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 11, 2022